David Matthew Wilson, Stevenage GB
David Matthew Wilson, Stevenage GB
Patent application number | Description | Published |
---|---|---|
20120202875 | Method Of Treatment - The present invention relates to methods for treatment or prevention of autoimmune and inflammatory diseases and conditions by inhibiting or modifying histone demethylation. In a further aspect the invention relates to a method for identifying agents useful in said methods of treatment. The invention particularly describes the role of certain histone demethylase enzymes in these diseases and conditions and their use as therapeutic and screening targets. | 08-09-2012 |
20120208798 | Tetrahydroquinoline Derivatives And Their Pharmaceutical Use - Tetrahydroquinoline compounds of formula (I) | 08-16-2012 |
20120232061 | NOVEL COMPOUNDS - A compound of formula (I): | 09-13-2012 |
20130040984 | 7-(lH-PYRAZOL-4-YL)-1,6-NAPHTHYRIDINE COMPOUNDS AS SYK INHIBITORS - The present invention relates to a compound of formula (I): | 02-14-2013 |
20130224204 | Method of Treatment Based on ATAD2 Inhibitors - A method of treating autoimmune and inflammatory diseases or conditions in a mammal, such as a human, which comprises the administration of a inhibitor of the bromodomain-containing protein: ATAD2. | 08-29-2013 |
20140005177 | PYRIDINYL- AND PYRAZINYL-METHYLOXY-ARYL DERIVATIVES USEFUL AS INHIBITORS OF SPLEEN TYROSINE KINASE (SYK) | 01-02-2014 |
20140005188 | PYRIDO[3,4-B]PYRAZINE DERIVATIVES AS SYK INHIBITORS | 01-02-2014 |
20140024558 | Method of Treatment - The present invention relates to methods for treatment or prevention of autoimmune and inflammatory diseases and conditions by inhibiting or modifying histone demethylation. In a further aspect the invention relates to a method for identifying agents useful in said methods of treatment. The invention particularly describes the role of certain histone demethylase enzymes in these diseases and conditions and their use as therapeutic and screening targets. | 01-23-2014 |